(Q43281611)

18 November 2017

Brain metabolic correlates of dopaminergic degeneration in de novo idiopathic Parkinson's disease (English)

1 reference

18 November 2017

1 reference

1 reference

11

1 reference

Maria Teresa De Cristofaro

18 November 2017

Eleonora Vanzi

4

0 references

object named as

Maria Teresa De Cristofaro

5

0 references

Sandro Sorbi

object named as

Sandro Sorbi

10

0 references

author name string

Valentina Berti

1

1 reference

18 November 2017

Cristina Polito

2

1 reference

18 November 2017

Silvia Ramat

3

1 reference

18 November 2017

Giannantonio Pellicanò

6

1 reference

18 November 2017

Francesco Mungai

7

1 reference

18 November 2017

Paolo Marini

8

1 reference

18 November 2017

Andreas Robert Formiconi

9

1 reference

18 November 2017

2 September 2009

1 reference

18 November 2017

8

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

18 November 2017

37

1 reference

18 November 2017

3

1 reference

18 November 2017

537-544

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-009-1259-x

18 November 2017

0 references

cites work

Parkinsonism: onset, progression, and mortality

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00259-009-1259-X

Least-squares fitting of two 3-d point sets.

21 January 2018

1 reference

12 December 2020

A unified statistical approach for determining significant signals in images of cerebral activation

1 reference

12 December 2020

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

1 reference

12 December 2020

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

1 reference

12 December 2020

The metabolic topography of parkinsonism

1 reference

12 December 2020

Cognitive- and motor-related regions in Parkinson's disease: FDOPA and FDG PET studies

1 reference

12 December 2020

Consensus nomenclature for in vivo imaging of reversibly binding radioligands

1 reference

12 December 2020

Executive processes in Parkinson's disease: FDG-PET and network analysis

1 reference

12 December 2020

Impact of chronic subthalamic high-frequency stimulation on metabolic basal ganglia activity: a 2-deoxyglucose uptake and cytochrome oxidase mRNA study in a macaque model of Parkinson's disease.

1 reference

12 December 2020

Clinical correlation of the binding potential with 123I-FP-CIT in de novo idiopathic Parkinson's disease patients

1 reference

12 December 2020

FDG PET in the differential diagnosis of parkinsonian disorders

1 reference

12 December 2020

How does Parkinson's disease begin? The role of compensatory mechanisms.

1 reference

12 December 2020

1 reference

12 December 2020

Modulation of regional brain function by deep brain stimulation: studies with positron emission tomography.

1 reference

12 December 2020

Changes in network activity with the progression of Parkinson's disease

1 reference

12 December 2020

The functional anatomy of basal ganglia disorders

1 reference

12 December 2020

Comparison of FP-CIT SPECT with F-DOPA PET in patients with de novo and advanced Parkinson's disease

1 reference

12 December 2020

Role of dopamine transporter imaging in routine clinical practice

1 reference

12 December 2020

Levodopa and the progression of Parkinson's disease

1 reference

12 December 2020

Accelerated image reconstruction using ordered subsets of projection data

1 reference

12 December 2020

Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies

1 reference

12 December 2020

Mapping of brain function after MPTP-induced neurotoxicity in a primate Parkinson's disease model.

1 reference

12 December 2020

Fronto-striatal connections in the human brain: a probabilistic diffusion tractography study

1 reference

12 December 2020

Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages).

1 reference

12 December 2020

[123I]FP-CIT striatal binding in early Parkinson's disease patients with tremor vs. akinetic-rigid onset.

1 reference

12 December 2020

Dissociation of metabolic and neurovascular responses to levodopa in the treatment of Parkinson's disease

1 reference

12 December 2020

Presymptomatic compensation in Parkinson's disease is not dopamine-mediated

1 reference

12 December 2020

Imaging studies in movement disorders

1 reference

12 December 2020

The basal ganglia: an overview of circuits and function

1 reference

12 December 2020

Striatal FP-CIT uptake differs in the subtypes of early Parkinson's disease.

1 reference

12 December 2020

Ageing and Parkinson's disease: substantia nigra regional selectivity

1 reference

12 December 2020

A direct ROI quantification method for inherent PVE correction: accuracy assessment in striatal SPECT measurements.

1 reference

12 December 2020

Reciprocal Benefits of Mass-Univariate and Multivariate Modeling in Brain Mapping: Applications to Event-Related Functional MRI, H(2) (15)O-, and FDG-PET

1 reference

12 December 2020

Least squares algorithm for region-of-interest evaluation in emission tomography.

1 reference

12 December 2020

The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism

1 reference

12 December 2020

Assessment of the progression of Parkinson's disease: a metabolic network approach

1 reference

12 December 2020

Parallel Organization of Functionally Segregated Circuits Linking Basal Ganglia and Cortex

1 reference

12 December 2020

Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.

1 reference

12 December 2020

Functional architecture of basal ganglia circuits: neural substrates of parallel processing

1 reference

12 December 2020

The basal ganglia in Parkinson's disease: current concepts and unexplained observations

1 reference

12 December 2020

Functional brain networks in Parkinson's disease

1 reference

12 December 2020

Corticostriatal covariance patterns of 6-[18F]fluoro-L-dopa and [18F]fluorodeoxyglucose PET in Parkinson's disease

1 reference

12 December 2020

The metabolic substrates of bradykinesia and tremor in uncomplicated Parkinson's disease

1 reference

12 December 2020

Vulnerability of cortical neurons to Alzheimer's and Parkinson's diseases.

1 reference

12 December 2020

10.1007/S00259-009-1259-X

Identifiers

DOI

1 reference

18 November 2017

1 reference